Announcements Trials
Browse Landscape

Status

Withdrawn 1Completed 1

Sponsor Class

OTHER 1

Study Type

Observational 1

Sponsor

Cancer Type

Tumor-Agnostic 1

Conditions

Neoplasms 2Colorectal Neoplasms 2Breast Neoplasms 2Vulvar Neoplasms 1Vaginal Neoplasms 1Triple Negative Breast Neoplasms 1Stomach Neoplasms 1Sleep Initiation and Maintenance Disorders 1Prostatic Neoplasms 1Patient Education 1Pancreatic Neoplasms 1Pain 1Ovarian Neoplasms 1Neoplasms, Plasma Cell 1Leukemia, Myeloid, Acute 1Leukemia, Myeloid 1Genital Neoplasms, Female 1Gastrointestinal Neoplasms 1Endometrial Neoplasms 1Delirium 1Cigarette Smoking-Related Carcinoma 1Cholangiocarcinoma 1Carcinoma, Squamous Cell 1Carcinoma 1Adenocarcinoma 1

Interventions

Gemcitabine 3Nivolumab 2temoporfin 1spartalizumab 1polysaccharide-K 1pembrolizumab 1nimotuzumab 1devimistat 1dalotuzumab 1bemarituzumab 1belinostat 1Transurethral Resection of Prostate 1Radiotherapy, Intensity-Modulated 1Radiotherapy 1Radiofrequency Ablation 1Oxaliplatin 1Morphine 1Methadone 1Leucovorin 1Ipilimumab 1Interviews as Topic 1Injections 1Immunotherapy 1Heavy Ion Radiotherapy 1Fluorouracil 1Erlotinib Hydrochloride 1Docetaxel 1Cryosurgery 1Cisplatin 1Brachytherapy 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Withdrawn × Adenocarcinoma × Interviews as Topic × Clear all
NCT01148082 2017-06-26

School Response to Families Who Have Children With Cancer

Stanford University

Withdrawn
Tumor-Agnostic

Adenocarcinoma, Carcinoma, Carcinoma, Squamous Cell

Data powered by HemOnc (CC BY 4.0) Colophon âš¡